Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments

George Busby, Scott Kulm, Alessandro Bolli, Jen Kintzle, Paolo Di Domenico, Giordano Bottà

Nature Communications · 2023

Read source ↗ All evidence

Summary

Clinical implementation of new prediction models requires evaluation of their utility in a broad range of intended use populations. Here we develop and validate ancestry-specific Polygenic Risk Scores (PRSs) for Coronary Artery Disease (CAD) using 29,389 individuals from diverse cohorts and genetic ancestry groups. The CAD PRSs outperform published scores with an average Odds Ratio per Standard Deviation of 1.57 (SD = 0.14) and identify between 12% and 24% of individuals with high genetic risk. Using this risk factor to reclassify borderline or intermediate 10 year Atherosclerotic Cardiovascular Disease (ASCVD) risk improves assessments for both CAD (Net Reclassification Improvement (NRI) = 13.14% (95% CI 9.23-17.06%)) and ASCVD (NRI = 10.70 (95% CI 7.35-14.05)) in an independent cohort of

Source type
Peer-reviewed study
DOI
10.1038/s41467-023-42897-w
Catalogue ID
SNmojad181-nv1qcu
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.